Regulator Directs Drug Manufacturers To Test Both Raw Materials And Finished Products After Cough Syrup Deaths

Following deaths linked to contaminated cough syrups, the drug regulator directed manufacturers to test both raw materials and finished products before batch release. This measure aims to enhance product safety and prevent health hazards associated with substandard pharmaceuticals. The directive reinforces stringent quality control in manufacturing, emphasizes compliance with regulatory standards, and seeks to restore public confidence in essential medicines. Manufacturers are required to adopt robust testing protocols and documentation practices to ensure consumer safety and accountability.